Literature DB >> 25143079

Scale up the supply of experimental Ebola drugs.

Oliver Brady.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25143079     DOI: 10.1038/512233a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  5 in total

Review 1.  Anti-Ebola therapies based on monoclonal antibodies: current state and challenges ahead.

Authors:  Everardo González-González; Mario Moisés Alvarez; Alan Roberto Márquez-Ipiña; Grissel Trujillo-de Santiago; Luis Mario Rodríguez-Martínez; Nasim Annabi; Ali Khademhosseini
Journal:  Crit Rev Biotechnol       Date:  2015-11-26       Impact factor: 8.429

2.  A comprehensive database of the geographic spread of past human Ebola outbreaks.

Authors:  Adrian Mylne; Oliver J Brady; Zhi Huang; David M Pigott; Nick Golding; Moritz U G Kraemer; Simon I Hay
Journal:  Sci Data       Date:  2014-10-23       Impact factor: 6.444

3.  Immunogenomic engineering of a plug-and-(dis)play hybridoma platform.

Authors:  Mark Pogson; Cristina Parola; William J Kelton; Paul Heuberger; Sai T Reddy
Journal:  Nat Commun       Date:  2016-08-17       Impact factor: 14.919

4.  [Ebola and emerging viruses].

Authors:  José María Eiros Bouza; Alberto Pérez-Rubio
Journal:  Aten Primaria       Date:  2015-02-07       Impact factor: 1.137

5.  Clinical Research and the Training of Host Country Investigators: Essential Health Priorities for Disease-Endemic Regions.

Authors:  Ousmane A Koita; Robert L Murphy; Saharé Fongoro; Boubakar Diallo; Seydou O Doumbia; Moussa Traoré; Donald J Krogstad
Journal:  Am J Trop Med Hyg       Date:  2015-11-23       Impact factor: 2.345

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.